Approval · Notice of Compliance 8566 · 2007
MIRENA: Notice of Compliance 8566
Issued January 30, 2007
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 8566
- Date
- January 30, 2007
- Company
- Bayer Inc.Elkhart, Indiana, United States
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Manufacturer name change
- Therapeutic class
- Progestogen
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| MIRENA | 02243005 | Marketed |
Medicinal ingredients
- LEVONORGESTREL 52 MG per INS